Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Charcot-Marie-Tooth Association - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10524
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charcot-Marie-Tooth Association (CMTA) is a healthcare service provider that offers healthcare services to patients suffering from charcot marie tooth disease. The association provides services such as public education, patient support, and research promotion. It offers services such as orthopedic surgery, physiatrist, neurology, genetics, physical therapy and podiatry areas. CMTA provides services through a network of clinics, research medical professionals, and healthcare centers. The association provides research grants, fellowship programs and related services. It caters services to patients, families and others. CMTA is headquartered in Chester, Pennsylvania, the US.

Charcot-Marie-Tooth Association – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Regenacy Pharma Enters into Co-Developmenmt Agreement with Charcot-Marie-Tooth Association 10
Charcot-Marie-Tooth Association Enters into Co-Development Agreement with Acceleron Pharma 11
New York Stem Cell Foundation Enters into Co-Development Agreement with Charcot-Marie-Tooth Association 12
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 13
Charcot-Marie-Tooth Association – Key Competitors 14
Charcot-Marie-Tooth Association – Key Employees 15
Charcot-Marie-Tooth Association – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Key Facts 2
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Charcot-Marie-Tooth Association, Deals By Therapy Area, 2012 to YTD 2018 8
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Regenacy Pharma Enters into Co-Developmenmt Agreement with Charcot-Marie-Tooth Association 10
Charcot-Marie-Tooth Association Enters into Co-Development Agreement with Acceleron Pharma 11
New York Stem Cell Foundation Enters into Co-Development Agreement with Charcot-Marie-Tooth Association 12
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 13
Charcot-Marie-Tooth Association, Key Competitors 14
Charcot-Marie-Tooth Association, Key Employees 15

List of Figures
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Charcot-Marie-Tooth Association, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Raymond James Financial Inc:戦略・SWOT・企業財務分析
    Raymond James Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Raymond James Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • VGI Global Media Public Co Ltd:企業の戦略・SWOT・財務分析
    VGI Global Media Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary VGI Global Media Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hologic, Inc.:企業の戦略・SWOT・財務情報
    Hologic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hologic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to id …
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Orpak Systems Limited:企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Korea Midland Power Co Ltd:発電所・企業SWOT分析
    Korea Midland Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Rizal Commercial Banking Corp (RCB):電力:M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Sigma Pharmaceuticals Limited:企業の戦略・SWOT・財務情報
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …
  • Outotec Oyj:企業の戦略・SWOT・財務情報
    Outotec Oyj - Strategy, SWOT and Corporate Finance Report Summary Outotec Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • J.W. Ostendorf Gmbh & Co Kg
    J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tyser & Co Limited:企業の戦略的SWOT分析
    Tyser & Co Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Seplat Petroleum Development Company Plc (SEPLAT):企業の財務・戦略的SWOT分析
    Seplat Petroleum Development Company Plc (SEPLAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆